-
$ARWR I'm in awe: crazily efficient mean max TRIG reduction of -95% in severe hypertrig patients following single dose of mere 50mg: http://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-reports-interim-clinical-data-cardiometabolic …$AKCA doesn't hold a candle. -
$ARWR interim results for ARO-APOC3 and ARO-ANG3 - just WOW!!!#RNAi#biotech#GameOnpic.twitter.com/liZBBeLrFZ
-
$ARWR Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 https://www.businesswire.com/news/home/20200205005824/en/Arrowhead-Reports-Interim-Clinical-Data-Cardiometabolic-Candidates … -
$arwr Arrowhead’s EASL abstract titled: Short-term treatment with RNA interference therapy, JNJ-3989, results in sustained hepatitis B surface antigen supression in patients with chronic hepatitis B receiving nucleos(t)ide analogue treatment Auditorium -
$ARWR newly issued U.S. Patent No. 10,550,391 today for "Organic Compositions to Treat Beta-ENaC-Related Diseases." Former$NVS &$ALNY IP acquired by@ArrowheadPharma. Treats:#CysticFibrosis#PHA1#LiddlesSyndrome#Hypertension#Alkalosis#Hypokalemia. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10550391.PN.&OS=PN/10550391&RS=PN/10550391 … -
-
$ARWR shorts should short more BECAUSE RNAis are All Placebos : ))) -
$ARWR - And HOW FAR he will go...Rnai/Trim works/8 in the pipeline to follow(Plus more). Just remember how much 1 drug from MDCO was worth, and x that by 8..WOW,,,JUST WOW.. Soon investors will see $74 in their rear view mirror. Been saying - BUY ARWR TOMORROW. -
$ARWR Arrowhead Pharma, afterhours 5min pic.twitter.com/MFjQvkme4u
-
$ARWR - Yahoo - BioBoyScout23 minutes ago As I stated before, no negative news and everything is proceeding as planned. There were some that gambled big-time that this was not the case - congrats to those that held firm. “I'll be back.” -The Terminator, 1984 ME - STRONG BUY -AM -
$ARWR HAHA So many questions, so much interest !! -
Per BBS... “we knew we had something” - b. given
$ARWR#RNAiLeader -
#estate asset watch - earnings after the close -$QCOM$TWLO$IRBT$PTON$GRUB$GPRO$ZNGA$PAYC$FEYE$PLUS$SAVE$ARWR$ORLY$CTSH$MET$SU$GLUU$ELF$CINF$YUMC$SONO$RGLD$ICHR$FORM$CCMP$DHT$COHR$FOXA$ANGI$IAC$OHI$CSL$ADTN$MHO$NTGR$AVB$FLO$FMC$CUZ$LCIpic.twitter.com/WdQQAsvqSi -
Expecting an update on all
$ARWR programs tomorrow, but especially the 4 they now show advancing in Phase on the pipeline. https://arrowheadpharma.com/pipeline/ APOC3 and ANG3 are now at PH2 while HSD and HIF2 are newly listed as phase 1 assets.#RNAi Progressing as expected -
Blackrock owns 12..3% of
$ARWR. Form SC 13G/A filing just came out -
$ARWR - Remember AMGEN, when looking @ investing in ARWR. Amgen in the 90's was around $86 an had 5 splits in 10 years. If you would have bought 1K shares, you would now have 48K during that period, by just investing. Our GOAL $81. Cond'tPrikaži ovu nit -
looks like
$ARWR is finding the bottom, imo. -
$ARWR Their attitude portends something different, imo. It reflects internal successes (those not yet externally disseminated). Meanwhile this objective truth remains, they’ve consistently met & thumped guidance for years. The street “pays” respect to results, not perceptions. -
$ARWR...AMG 890 Phase 2 to begin in H1 2020...CC slide 35 pic.twitter.com/qJ9dfjxxy5
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
